RE: That missed boat again?21 May 2022 11:03
AIHL has no competition and is needed now and needed everywhere in the world. It will still be needed for the next few years. Its potential is enormous. Very different situation for the Covid POC kit which has shown Budd to be a poor judge in , when, how and where to direct time, money and resources in developing new products and getting them to market.
AIHL can’t be compared for many reasons however. All will be well but obv patience required. Please ignore idiots who say this is going to be £1 by the end of the week or month. They know nothing and are just blind rampers hoping for a spike so they can exit fast. Their posts are based on nothing but hope, desperation and thin air.
For investors willing to wait perhaps 12 months for this to turn round GDR is an exciting prospect. CTDA news will now have no impact and is indeed far too late. AIHL on the other hand has immense potential and will reward investors. Just not in the next 5 minutes.
With no competition for AIHL and a global and permanent market, this hopefully puts GDR at the forefront of this new technology which is going to be at the forefront of medical care going forwards. As such this I think means there is always a possibility, albeit perhaps only a small one, that GDR will be the target of a takeover. As I say, the potential is enormous.